Altis Biologics (Pty) Ltd is a company specializing in the research and development of osteogenic biomaterials for use in skeletal regeneration therapies in man.
The technological basis underlying Altis Osteogenic Bone Matrix (OBM) are the bone morphogenetic proteins (BMPs), a family of growth factors capable of inducing new bone formation commencing shortly after implantation into human recipients. The company has also developed an injectable delivery system based entirely on bone matrix.
The company also specializes in the purification of type I collagen from porcine bone matrix, which is used as delivery system for porcine BMP complex.
Altis OBM is an implant material intended as an alternative or substitute to traditional bone graft products, which usually involve the harvest of bone from the patient’s own hip, or which employ allograft donor bone supplied by bone tissue banks. Altis OBM is injected into the skeletal site requiring regeneration of new bone, without the need to perform a second bone graft operation. Altis OBM may offer a safe and effective alternative to traditional autogenous grafting procedures still in popular use today.
Contact
Unit U1
The Innovation Centre
Mark Shuttleworth Street at The Innovation Hub
0087
Pretoria
South Africa
Nicolaas Duneas
Tel: +27 12 844-0098
E-mail: nic@altisbiologics.com
Mobile: +27 82 853-0644
The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM) and how the company plans to commercialize the injectable bone…
Mrs. Reid, how would you define and describe the generic part of the South African pharmaceutical market? Linda Reid: South Africa is very much a branded generics market, and not…
In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar to you, considering your significant experience in these countries. How would you compare…
Ms Beaumont, can you describe the association to our readers and its main objectives? Innovative Medicines South Africa (IMSA) represents manufacturers of research-based medicines, ie they market the products of…
See our Cookie Privacy Policy Here
